Effects of concomitant antiepileptic drugs on serum carbamazepine concentration in epileptic patients: Quantitative analysis based on extracellular water volume as a transforming factor

Yakugaku Zasshi

Volumn 123, Issue 1, 2003, Pages 35-42

  Fukuoka, Noriyasu ^a   Tsukamoto, Toyohisa ^a   Uno, Junji ^b   Kimura, Michio ^c   Morita, Shushi ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b Okehazama Hospital   (Japan)

^c KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Alteration ratio; Antiepileptic drug; Carbamazepine; Concomitant therapy; Serum concentration

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID; ZONISAMIDE;

ADULT; ARTICLE; CALCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MONITORING; EPILEPSY; EXTRACELLULAR FLUID; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; VALIDATION PROCESS; ADOLESCENT; AGED; BLOOD; BODY WATER; CHILD; DRUG COMBINATION; DRUG INTERACTION; EXTRACELLULAR SPACE; INFANT; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; BODY WATER; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EXTRACELLULAR SPACE; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED;

EID: 0037264931     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi.123.35     Document Type: Article

References (22)

1. Duncan J. S., Patsalos P. N., Shorvon S. D., Epilepsia, 32, 101-155 (1991).
2. Pippenger C. E., Epilepsia, 23, 81-86 (1982).
3. Ijiri Y., Ohi K., Suzuki K., Kobayashi T., Fukuoka E., Furuya T., Tamai H., Wakamiya E., Mino M., Yoshinari S., Jpn. J. Hosp. Pharm., 22, 81-88 (1996).
4. Suzuki Y., Cox S., Hayes J., Walson P. D., Ther. Drug Monit., 13, 201-208 (1991).
5. Suzuki A., Yukawa E., Ohtsubo K., Ieiri I., Teshima D., Higuchi S., Aoyama T., Jpn. J. Hosp. Pharm., 17, 26-33 (1991).
6. Kihira K., Tanaka N., Kimura Y., Miyake K., Kitaura T., Fukuchi H., Jpn. J. Hosp. Pharm., 21, 276-281 (1995).
7. Battino D., Bossi L., Croci D., Franceschetti S., Gomeni C., Moise A., Vitali A., Ther. Drug Monit., 2, 315-322 (1980).
8. Lander C. M., Eadie M. J., Tyrer J. H., Clin. Exp. Neurol., 14, 184-193 (1977).
9. Christiansen J., Dam M., Acta Neurol. Scand., 49, 543-546 (1973).
10. Fukuoka N., Tsukamoto T., Uno J., Kimura M., Morita S., Jpn. J. Hosp. Pharm., 26, 135-144 (2000).
11. Fukuoka N., Tsukamoto T., Uno J., Kimura M., Morita S., Jpn. J. Hosp. Pharm., 24, 642-651 (1998).
12. Fukuoka N., Tsukamoto T., Uno J., Kimura M., Morita S., Jpn. J. Hosp. Pharm., 24, 652-660 (1998).
13. Aoki S., "Tokei Program Package NAP (ver. 4.0) Manual," Igaku Shoin, Tokyo, 1995.
14. Friis-Hansen B., Pediatrics, 28, 169-181 (1961).
15. Snedecor G. W., Cochran W. G., "Statistical Methods, 6th edn.," translated by Hatamura M., Okuno C., Tsumura Y., Iwanami Shoten, Tokyo, 1974, pp. 405-408.
16. Bertilsson L., Hojer B., Tybring G., Osterloh J., Rane A., Clin. Pharmacol. Ther., 27, 83-88 (1980).
17. Kugoh T., "Tenkangaku no Rinshou," Seiwa Shoten, Tokyo, 1996, pp. 361-364.
18. Hosoya J., Nagaoka H., Ishikawa S., Nakagawa Y., Higashitani Y., Totsuka S., Jpn. J. Hosp. Pharm., 16, 277-287 (1990).
19. Kihira M., Tanaka N., Kimura Y., Miyake K., Kitaura T., Fukuchi H., Biol. Pharm. Bull., 16, 722-725 (1993).
20. Hori R., Okumura K., Kitazawa S., Koshiro A., Saitoh Y., Higuchi S., Mizugaki M., Yamaji A., Rikihisa T., Tanigawara Y., Yakuzaigaku, 49, 304-312 (1989).
21. Nakashima M., Ueshima Y., Hirai M., Nakashima M., Tatsuo E., Nakaboh Y., Kamimura N., Matsuzaka T., Tsuji Y., Ichikawa M., TDM Kenkyu, 13, 56-60 (1996).
22. Konishi H., Morita K., Ono T., Shimakawa H., Yakuzaigaku, 50, 323-328 (1990).